HLN Haleon plc
$10.08▼ -1.18%
Healthcare
Other
After hours
$10.08▲ +0.00%
Oct 27, 5:05 PM ET
Volume 15.86M
Avg Volume (10D) 16.06M
Key Metrics & Fundamentals
Market Cap
$44.33B
P/E Ratio
20.6
Div Yield
1.94%
52W Range
8.65 - 11.28
% vs 50 MA
5.19%
% vs 200 MA
3.10%
RSI-14
60.8
MACD Histogram
+0.0800
Beta (1Y vs SPY)
-0.11
Gross Rev
$2.76B
Gross Profit
$1.53B
EBITDA
$362.00M
COGS
$1.23B
Operating Exp
$1.18B
Operating Income
$350.00M
EBIT
$350.00M
Pretax Income
$288.00M
Net Income
$231.00M
Price & Volume History
Loading chart…
Recent News
Haleon Heads These 3 British AI Healthcare Stocks To Watch
Simply Wall St. · Oct 25, 2026 5:09 AM ET
UBS says early flu pick-up could lift 2027 earnings at Reckitt and Haleon
Proactive · Oct 20, 2026 11:00 AM ET
Haleon Launches ‘Haleon Health House,’ a One-Day Interactive Wellness Pop-Up in Toronto
GlobeNewswire · Oct 19, 2026 7:00 AM ET
Will Headache Remedy Launch Change Haleon's (LSE:HLN) Narrative
Simply Wall St. · Oct 18, 2026 4:17 AM ET
Haleon And 2 British AI Healthcare Stocks To Watch
Simply Wall St. · Oct 18, 2026 4:09 AM ET
Is Haleon (LSE:HLN) Using Excedrin’s Nostalgic Game To Redefine Consumer Health Brand Moats?
Simply Wall St. · Oct 14, 2026 9:11 PM ET
Is Haleon (LSE:HLN) Undervalued After A 11% Three Year Return?
Simply Wall St. · Oct 14, 2026 12:33 AM ET
Haleon (LSE:HLN) Unveils Excedrin Push, Is The Valuation Gap An Opportunity?
Simply Wall St. · Oct 13, 2026 10:10 PM ET
Only Excedrin Brings Digital Pet Nostalgia Back with a Headache You Can't Ignore
PR Newswire · Oct 12, 2026 6:20 AM ET
3 British AI Healthcare Stocks With At Least 4% Revenue Growth
Simply Wall St. · Oct 11, 2026 3:10 AM ET
Financial Overview - Income Statement
Quarterly
Dec 2024
See HLN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.